Therapy-induced antibodies against the antiviral and antiproliferative effects of interferons in patients with chronic hepatitis C virus infection

Erzsébet Bálint, Márta Bakay, Klára Ónody, F. Farkas, G. Horváth, G. Y. Tolvaj, K. Dávid, M. Horányi, Ilona Béládi

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Sera from 86 patients with chronic hepatitis C virus (HCV) infection treated with recombinant interferons-α (rIFN-α) were screened for IFN-binding and antiviral effect-neutralizing antibodies. Out of the 61 patients treated with rIFN-α2b, 46% had binding and 28% had neutralizing antibodies. 44% of the 25 patients treated with rIFN-α2a developed binding antibodies and 24% had neutralizing antibodies. Contradictory data were observed concerning the appearance of anti-IFN antibodies and the outcome of IFN therapy. A significantly higher number of the patients with a sustained response to rIFN-α2b therapy formed antibodies than the number among the non-responder patients. At the same time, in the patients treated with rIFN-α2a, opposite data were found. The activity of the antibodies in some sera was studied against the anti-proliferative effect of IFNs on Daudi cells by measuring the [3H]thymidine incorporation. The binding antibodies without neutralization of the antiviral effect of the IFNs inhibited the antiproliferative activity of the rIFNs, similarly to antibodies having both IFN-binding and antiviral effect-neutralizing capacities. At the same time, the anti-proliferative effect of the natural IFN was less affected. It is suggested that the antiproliferative assay is more sensitive than the antiviral method for demonstration of the presence of antibodies exerting an inhibitory effect on the biological activities of IFN.

Original languageEnglish
Pages (from-to)359-369
Number of pages11
JournalActa Microbiologica et Immunologica Hungarica
Volume51
Issue number3
DOIs
Publication statusPublished - 2004

Fingerprint

Chronic Hepatitis C
Virus Diseases
Hepacivirus
Interferons
Antiviral Agents
Antibodies
Neutralizing Antibodies
Therapeutics
Serum
Thymidine
Anti-Idiotypic Antibodies

Keywords

  • Anti-interferon antibodies
  • Antiviral and antiproliferative effects of interferon
  • Chronic hepatitis C virus infection
  • Natural and recombinant interferons

ASJC Scopus subject areas

  • Immunology and Microbiology(all)
  • Medicine(all)
  • Microbiology

Cite this

Therapy-induced antibodies against the antiviral and antiproliferative effects of interferons in patients with chronic hepatitis C virus infection. / Bálint, Erzsébet; Bakay, Márta; Ónody, Klára; Farkas, F.; Horváth, G.; Tolvaj, G. Y.; Dávid, K.; Horányi, M.; Béládi, Ilona.

In: Acta Microbiologica et Immunologica Hungarica, Vol. 51, No. 3, 2004, p. 359-369.

Research output: Contribution to journalArticle

Bálint, Erzsébet ; Bakay, Márta ; Ónody, Klára ; Farkas, F. ; Horváth, G. ; Tolvaj, G. Y. ; Dávid, K. ; Horányi, M. ; Béládi, Ilona. / Therapy-induced antibodies against the antiviral and antiproliferative effects of interferons in patients with chronic hepatitis C virus infection. In: Acta Microbiologica et Immunologica Hungarica. 2004 ; Vol. 51, No. 3. pp. 359-369.
@article{68b6468cbdd1415c9daac2c07bff8a32,
title = "Therapy-induced antibodies against the antiviral and antiproliferative effects of interferons in patients with chronic hepatitis C virus infection",
abstract = "Sera from 86 patients with chronic hepatitis C virus (HCV) infection treated with recombinant interferons-α (rIFN-α) were screened for IFN-binding and antiviral effect-neutralizing antibodies. Out of the 61 patients treated with rIFN-α2b, 46{\%} had binding and 28{\%} had neutralizing antibodies. 44{\%} of the 25 patients treated with rIFN-α2a developed binding antibodies and 24{\%} had neutralizing antibodies. Contradictory data were observed concerning the appearance of anti-IFN antibodies and the outcome of IFN therapy. A significantly higher number of the patients with a sustained response to rIFN-α2b therapy formed antibodies than the number among the non-responder patients. At the same time, in the patients treated with rIFN-α2a, opposite data were found. The activity of the antibodies in some sera was studied against the anti-proliferative effect of IFNs on Daudi cells by measuring the [3H]thymidine incorporation. The binding antibodies without neutralization of the antiviral effect of the IFNs inhibited the antiproliferative activity of the rIFNs, similarly to antibodies having both IFN-binding and antiviral effect-neutralizing capacities. At the same time, the anti-proliferative effect of the natural IFN was less affected. It is suggested that the antiproliferative assay is more sensitive than the antiviral method for demonstration of the presence of antibodies exerting an inhibitory effect on the biological activities of IFN.",
keywords = "Anti-interferon antibodies, Antiviral and antiproliferative effects of interferon, Chronic hepatitis C virus infection, Natural and recombinant interferons",
author = "Erzs{\'e}bet B{\'a}lint and M{\'a}rta Bakay and Kl{\'a}ra {\'O}nody and F. Farkas and G. Horv{\'a}th and Tolvaj, {G. Y.} and K. D{\'a}vid and M. Hor{\'a}nyi and Ilona B{\'e}l{\'a}di",
year = "2004",
doi = "10.1556/AMicr.51.2004.3.13",
language = "English",
volume = "51",
pages = "359--369",
journal = "Acta Microbiologica et Immunologica Hungarica",
issn = "1217-8950",
publisher = "Akademiai Kiado",
number = "3",

}

TY - JOUR

T1 - Therapy-induced antibodies against the antiviral and antiproliferative effects of interferons in patients with chronic hepatitis C virus infection

AU - Bálint, Erzsébet

AU - Bakay, Márta

AU - Ónody, Klára

AU - Farkas, F.

AU - Horváth, G.

AU - Tolvaj, G. Y.

AU - Dávid, K.

AU - Horányi, M.

AU - Béládi, Ilona

PY - 2004

Y1 - 2004

N2 - Sera from 86 patients with chronic hepatitis C virus (HCV) infection treated with recombinant interferons-α (rIFN-α) were screened for IFN-binding and antiviral effect-neutralizing antibodies. Out of the 61 patients treated with rIFN-α2b, 46% had binding and 28% had neutralizing antibodies. 44% of the 25 patients treated with rIFN-α2a developed binding antibodies and 24% had neutralizing antibodies. Contradictory data were observed concerning the appearance of anti-IFN antibodies and the outcome of IFN therapy. A significantly higher number of the patients with a sustained response to rIFN-α2b therapy formed antibodies than the number among the non-responder patients. At the same time, in the patients treated with rIFN-α2a, opposite data were found. The activity of the antibodies in some sera was studied against the anti-proliferative effect of IFNs on Daudi cells by measuring the [3H]thymidine incorporation. The binding antibodies without neutralization of the antiviral effect of the IFNs inhibited the antiproliferative activity of the rIFNs, similarly to antibodies having both IFN-binding and antiviral effect-neutralizing capacities. At the same time, the anti-proliferative effect of the natural IFN was less affected. It is suggested that the antiproliferative assay is more sensitive than the antiviral method for demonstration of the presence of antibodies exerting an inhibitory effect on the biological activities of IFN.

AB - Sera from 86 patients with chronic hepatitis C virus (HCV) infection treated with recombinant interferons-α (rIFN-α) were screened for IFN-binding and antiviral effect-neutralizing antibodies. Out of the 61 patients treated with rIFN-α2b, 46% had binding and 28% had neutralizing antibodies. 44% of the 25 patients treated with rIFN-α2a developed binding antibodies and 24% had neutralizing antibodies. Contradictory data were observed concerning the appearance of anti-IFN antibodies and the outcome of IFN therapy. A significantly higher number of the patients with a sustained response to rIFN-α2b therapy formed antibodies than the number among the non-responder patients. At the same time, in the patients treated with rIFN-α2a, opposite data were found. The activity of the antibodies in some sera was studied against the anti-proliferative effect of IFNs on Daudi cells by measuring the [3H]thymidine incorporation. The binding antibodies without neutralization of the antiviral effect of the IFNs inhibited the antiproliferative activity of the rIFNs, similarly to antibodies having both IFN-binding and antiviral effect-neutralizing capacities. At the same time, the anti-proliferative effect of the natural IFN was less affected. It is suggested that the antiproliferative assay is more sensitive than the antiviral method for demonstration of the presence of antibodies exerting an inhibitory effect on the biological activities of IFN.

KW - Anti-interferon antibodies

KW - Antiviral and antiproliferative effects of interferon

KW - Chronic hepatitis C virus infection

KW - Natural and recombinant interferons

UR - http://www.scopus.com/inward/record.url?scp=8844250085&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=8844250085&partnerID=8YFLogxK

U2 - 10.1556/AMicr.51.2004.3.13

DO - 10.1556/AMicr.51.2004.3.13

M3 - Article

C2 - 15571075

AN - SCOPUS:8844250085

VL - 51

SP - 359

EP - 369

JO - Acta Microbiologica et Immunologica Hungarica

JF - Acta Microbiologica et Immunologica Hungarica

SN - 1217-8950

IS - 3

ER -